ARM
NASDAQ · Technology
Arm Holdings plc
$135.20
-1.69 (-1.23%)
ARM News30 articles
NVIDIA Shares Hover at $175 Amid Senate Scrutiny Over China Exports
NVIDIA shares remained near $175.20 in premarket trading as senators urged a review of its chip export licenses to China. The company's outlook assumes no China data-center revenue.
Intel Shares Surge on AI Server Demand, Arm Chip Launch
Intel shares climbed 3.8% ahead of Wednesday's opening bell, buoyed by Arm's launch of a new AI data-center processor and renewed focus on server CPU demand. The chipmaker's market valuation reached approximately $155.4 billion.
Qualcomm Faces Memory Chip Squeeze as DRAM Prices Surge 75%
Qualcomm shares rose 1.6% to $140.70 on Friday before the holiday pause, as a sharp rise in memory chip costs threatens smartphone makers and suppliers. The company has previously warned that tighter memory supply could dampen handset demand.
Qualcomm Shares Gain Amid Analyst Caution Over Memory Supply Constraints
Qualcomm stock rose 0.5% to $139.61, stabilizing after recent volatility. Morgan Stanley resumed coverage with an underweight rating and a $132 target, citing memory shortages and weak handset demand.
Qualcomm Gains on 2nm Chip Milestone Amid Memory Supply Concerns
Qualcomm shares advanced 0.9% after announcing a key 2-nanometer chip design achievement from its India engineering centers, partially recovering from last week's decline. The company continues to face headwinds from memory chip shortages impacting smartphone production.
Arm Stock Surges on AI Data Center Optimism, Faces Smartphone Headwinds
Arm Holdings shares rallied sharply Friday, extending a two-day rebound as chip stocks gained on AI infrastructure spending hopes, though memory constraints threaten smartphone royalty revenue.
Merck Acquires Terns Pharma in $6.7B Deal to Fortify Cancer Portfolio
Merck will purchase Terns Pharmaceuticals for $53 per share in cash, a transaction valued at approximately $6.7 billion. The acquisition provides Merck with an experimental leukemia therapy as it prepares for the loss of exclusivity for its blockbuster drug Keytruda.
Swarmer Shares Plunge 30% Post-IPO, Highlighting Volatility Risks
Swarmer's stock tumbled over 30% in Friday's session, a sharp reversal after its Nasdaq debut. Despite the drop, shares trade significantly above the initial offering price set last week.
AeroVironment Secures $135M Army Drone Deals Amid Strategic Shifts
Defense contractor AeroVironment has been awarded nearly $135 million in new orders from the U.S. Army for its P550 long-range reconnaissance and Red Dragon attack drone systems. The contracts arrive shortly after the company lowered its revenue forecast and recorded a significant goodwill impairment.
Swarmer Soars Post-IPO as Battle-Tested Drone Software Captures Investor Interest
Swarmer shares skyrocketed 77% to $55, building on a 520% first-day pop from its $5 IPO price. The drone software firm, with over 100,000 combat missions in Ukraine, faces significant financial challenges and customer concentration risks.
Natural Gas Futures Slide on Warm March Outlook, EIA Trims 2026 Forecast
U.S. natural gas futures declined sharply Friday, pressured by forecasts for mild late-winter weather reducing heating demand. The Energy Information Administration reduced its 2026 Henry Hub price outlook due to elevated storage inventories.
BAE Systems Secures Major Danish Army Training Contract Amid European Defense Surge
BAE Systems has secured a seven-year contract to provide advanced training software to the Danish Army, reflecting heightened defense spending across Europe. The deal coincides with NATO Arctic exercises and Denmark's plan to increase military expenditure to 3.2% of GDP by 2025.
Rolls-Royce Deepens Polish Defense Partnership Amid European Arms Surge
Rolls-Royce has entered a preliminary agreement with Poland's state-backed defense group PGZ to broaden collaboration on propulsion systems for military land and sea platforms. The move aligns with a significant increase in European arms imports and Poland's push to access EU military funding.
Servier Acquires Day One Biopharmaceuticals in $2.5 Billion Oncology Deal
French pharmaceutical firm Servier will acquire Day One Biopharmaceuticals for $2.5 billion, gaining the pediatric glioma treatment Ojemda. The deal offers a 68% premium to Day One's recent closing price.
Reviva Pharma Enacts Reverse Split to Fend Off Nasdaq Delisting
Reviva Pharmaceuticals Holdings has implemented a 1-for-20 reverse stock split to boost its share price and avoid a Nasdaq delisting, with a critical compliance deadline of March 27. The company also faces financing challenges for an additional Phase 3 trial of its schizophrenia drug candidate, brilaroxazine.
Garmin's fēnix 8 Pro Clinches Top MWC 2026 Award Amid Strong Fitness Growth
Garmin Ltd. secured the 'Best Connected Consumer Device' award at Mobile World Congress for its fēnix 8 Pro smartwatch. The recognition comes after the company reported a 42% jump in fitness segment revenue and issued an optimistic 2026 sales outlook.
BigBear.ai Stock Gains Despite Target Cuts as Army Sales Decline
BigBear.ai Holdings saw its stock climb roughly 5.5% in premarket trading Friday, even as two brokerages reduced price targets following a disappointing quarterly report. The defense AI firm reported a 38% drop in Q4 revenue to $27.3 million.
Zealand Pharma Stock Crashes on Obesity Drug Data Lagging Lilly
Zealand Pharma A/S shares plunged over 32% Friday after mid-stage trial results for its obesity drug candidate petrelintide showed weight loss well behind Eli Lilly's competing therapy, erasing billions in market value.
Wesfarmers' CSBP Warns of Fertilizer Delays Amid Persian Gulf Disruption
CSBP has alerted customers to potential delays in ammonium phosphate and urea shipments due to Middle East shipping disruptions. The company confirmed March collections will proceed but cannot accelerate April contracts.
Tesla's EU Emissions Pool Loses Key Carmakers for 2026
Stellantis, Toyota, and Subaru have not joined Tesla's 2026 EU carbon-credit pool, filings show, a shift from 2025. Tesla's regulatory credit revenue declined 28% to $1.99 billion last year.
Wesfarmers Shares Drop 5% in Two Days Amid ASX Selloff
Wesfarmers shares declined for a second consecutive session, dropping roughly 5% over two days as broader Asian markets sold off on geopolitical concerns and oil price volatility.
Wesfarmers Gains Amid ACCC Scrutiny of Bunnings-Uber Eats Pact
Wesfarmers Limited closed higher following a complaint filed with regulators over Bunnings' exclusive delivery partnership with Uber Eats. The company's dividend reinvestment plan pricing window is now open.
Wesfarmers Gains Amid ACCC Complaint Over Bunnings-Uber Eats Pact
Wesfarmers shares closed higher despite volatility after Mitre 10 lodged a competition complaint over Bunnings' exclusive delivery partnership with Uber Eats. The dividend reinvestment plan pricing period is now active.
Karman Holdings Retreats After Citi-Driven Surge; Eyes March Conference
Karman Holdings stock declined 4% to $84.85, partially reversing a sharp two-session advance. Citigroup maintains a Buy rating with a $125 target, citing stronger demand signals.
Wesfarmers Shares Slip Despite Profit Beat as Investors Eye Consumer Outlook
Wesfarmers reported higher first-half earnings and raised its dividend, but shares declined as management warned of patchy consumer demand and outlined price investment plans funded by productivity gains.
Wesfarmers Shares Slide Despite Profit Beat as Consumer Spending Concerns Mount
Wesfarmers shares tumbled over 5% despite reporting a half-year profit beat, as management flagged patchy consumer spending and upcoming price investments, overshadowing solid financial results.
Wesfarmers Gains Ahead of Key Half-Year Report
Wesfarmers Ltd edged higher ahead of its half-year financial report, with the market focused on retail performance and forward outlook. The broader ASX 200 index also advanced.
Wesfarmers Gains Ahead of Key Half-Year Results Release
Wesfarmers shares edged higher Tuesday, closing up 0.3% at A$88.98, as the market anticipates the conglomerate's half-year financial results scheduled for release this Thursday.
Natural Gas Futures Slide Toward $3 as Warm Weather Forecasts Pressure Market
U.S. natural gas futures dropped sharply Monday, pushing the March contract toward $3 per MMBtu amid mild weather forecasts and a smaller-than-expected storage withdrawal. The United States Natural Gas Fund (UNG) ended Friday at $12.44.
Phio Pharmaceuticals Shares Surge on Positive Skin Cancer Trial Data
Phio Pharmaceuticals stock climbed nearly 10% premarket following encouraging safety and efficacy results from a Phase 1b skin cancer study. The company targets an FDA submission in the second quarter of 2026.